Inactive Instrument

InterMune Inc Stock

Stocks

End-of-day quote Nasdaq
- ^USD	-

17/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE

17/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE
28/08/14	Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	RE
26/08/14	Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	RE
25/08/14	CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	RE
19/03/14	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
07/06/13	NVIDIA Corporation : SAC insider-trading probe could last years	RE
21/03/13	Weight Watchers International, Inc. : SAC Capital up 4 percent this year as probe continues	RE
16/03/13	Morgan Stanley : Cohen's SAC to pay $616 million in SEC insider trade settlement	RE
28/12/12	InterMune, Inc. : Blackstone seen sticking with SAC despite insider trading probe	RE
19/12/12	Weight Watchers International, Inc. : SAC Capital's top consumer trader draws U.S. scrutiny	RE
08/12/12	Elan Corporation, plc : Exclusive: U.S. authorities probe SAC for Weight Watchers - sources	RE
23/07/12	InterMune, Inc. : InterMune posts lower-than-expected revenue	RE

02/10/14	InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	PU
20/09/14	InterMune : Reports Memorandum of Understanding in Connection with Consolidated Delaware Action	PR
05/09/14	InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	PR
28/08/14	InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
27/08/14	InterMune : INVESTOR ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG	BU

04/09/14	Roche : exclut une mega-fusion, ouvert à de plus petits rachats
26/08/14	Wall Street finit dans le vert, le S&P passe un cap
25/08/14	Burger King Worldwide : Wall Street ouvre en hausse sur un nouveau record du S&P
25/08/14	Wall Street ouvre en hausse avec les M&A et l'Europe
25/08/14	Apple : USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Mark Thompson CEO	Chief Executive Officer	57	-
Marianne T. Armstrong CTO	Chief Tech/Sci/R&D Officer	71	01/04/2002
Carla Fiankan LAW	General Counsel	-	01/08/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+0.34%	-3.03%	+37.45%	+61.06%	64.14B
ARGENX SE	+0.98%	+2.68%	+12.25%	+83.90%	55.53B
LONZA GROUP AG	+1.75%	+2.01%	+13.30%	+105.71%	53.03B
IQVIA HOLDINGS INC.	-1.55%	-1.49%	+25.87%	+54.76%	45.99B
BEONE MEDICINES AG	-1.13%	-3.39%	+17.29%	+97.90%	42.45B
REVOLUTION MEDICINES, INC.	-0.39%	+0.04%	+223.62%	+923.24%	40.45B
CELLTRION, INC.	-0.26%	-4.20%	+10.86%	+45.18%	32.25B
GENMAB A/S	-2.07%	+42.73%	+103.77%	+90.26%	34.47B
WUXI BIOLOGICS (CAYMAN) INC.	-2.72%	-8.79%	+22.58%	-5.63%	24.23B
Average	-0.58%	+3.82%	+51.89%	+161.82%	43.62B
Weighted average by Cap.	-0.31%	+3.13%	+48.99%	+159.56%